Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis
- 1 December 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 287 (6), G1131-G1139
- https://doi.org/10.1152/ajpgi.00216.2004
Abstract
Cholinergic mechanisms are largely responsible for esophageal contraction in response to swallowing or to in vitro electrical field stimulation (EFS). After induction of experimental esophagitis by repeated acid perfusion, the responses to swallowing and to EFS were significantly reduced but contraction in response to ACh was not affected, suggesting that cholinergic mechanisms are damaged by acid perfusion but that myogenic mechanisms are not. Measurements of ACh release in response to EFS confirmed that release of ACh was reduced in esophagitis compared with normal controls. To examine factors contributing to this neuropathy, normal esophageal strips were incubated for 1–2 h with the proinflammatory cytokines IL-1β (100 U/ml), IL-6 (1 ng/ml), or TNF-α (1 ng/ml). IL-1β and IL-6 levels, measured by Western blot analysis, increased in esophagitis compared with normal circular muscle. IL-1β and IL-6 reduced contraction in response to EFS (2–10 Hz, 0.2 ms) but did not affect ACh-induced contraction, suggesting that these cytokines inhibit ACh release without affecting myogenic contractile mechanisms. EFS-induced ACh release was significantly reduced in normal esophageal strips by incubation in IL-1β or IL-6, suggesting that they may contribute to the contractility changes. TNF-α at 1 ng/ml, however, did not affect the response to ACh or to electrical stimulation but inhibited both at higher concentrations. TNF-α levels were low in normal muscle and did not increase with esophagitis. The data suggest that the proinflammatory cytokines IL-1β and IL-6 contribute to reduced esophageal contraction by inhibiting release of ACh from myenteric neurons.Keywords
This publication has 49 references indexed in Scilit:
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisGastroenterology, 1999
- Interleukin 1β induces the expression of interleukin 6 in rat intestinal smooth muscle cellsGastroenterology, 1995
- Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependentDigestive Diseases and Sciences, 1995
- Fourth Isoform of Preprotachykinin Messenger RNA Encoding for Substance P in the Rat IntestineBiochemical and Biophysical Research Communications, 1994
- Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.JCI Insight, 1994
- Colonic Mucosal Interleukin 1 Receptor Antagonist in Inflammatory Bowel DiseaseDigestion, 1994
- Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.Gut, 1992
- Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel diseaseDigestive Diseases and Sciences, 1992
- Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.Gut, 1989
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976